92 related articles for article (PubMed ID: 12694810)
1. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640.
Bruins Slot LA; Koek W; Tarayre JP; Colpaert FC
Eur J Pharmacol; 2003 Apr; 466(3):271-9. PubMed ID: 12694810
[TBL] [Abstract][Full Text] [Related]
2. Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia.
Colpaert FC; Tarayre JP; Koek W; Pauwels PJ; Bardin L; Xu XJ; Wiesenfeld-Hallin Z; Cosi C; Carilla-Durand E; Assié MB; Vacher B
Neuropharmacology; 2002 Nov; 43(6):945-58. PubMed ID: 12423664
[TBL] [Abstract][Full Text] [Related]
3. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist.
Deseure K; Bréand S; Colpaert FC
Eur J Pharmacol; 2007 Jul; 568(1-3):134-41. PubMed ID: 17512927
[TBL] [Abstract][Full Text] [Related]
4. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters.
Bardin L; Assié MB; Pélissou M; Royer-Urios I; Newman-Tancredi A; Ribet JP; Sautel F; Koek W; Colpaert FC
J Pharmacol Exp Ther; 2005 Mar; 312(3):1034-42. PubMed ID: 15528450
[TBL] [Abstract][Full Text] [Related]
5. Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain.
Deseure K; Koek W; Adriaensen H; Colpaert FC
J Pharmacol Exp Ther; 2003 Aug; 306(2):505-14. PubMed ID: 12730352
[TBL] [Abstract][Full Text] [Related]
6. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning.
Colpaert FC; Deseure K; Stinus L; Adriaensen H
J Pharmacol Exp Ther; 2006 Feb; 316(2):892-9. PubMed ID: 16254131
[TBL] [Abstract][Full Text] [Related]
7. The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain.
Deseure K; Koek W; Colpaert FC; Adriaensen H
Eur J Pharmacol; 2002 Dec; 456(1-3):51-7. PubMed ID: 12450569
[TBL] [Abstract][Full Text] [Related]
8. The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain.
Kiss I; Degryse AD; Bardin L; Gomez de Segura IA; Colpaert FC
Eur J Pharmacol; 2005 Oct; 523(1-3):29-39. PubMed ID: 16226246
[TBL] [Abstract][Full Text] [Related]
9. Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain.
Bardin L; Tarayre JP; Malfetes N; Koek W; Colpaert FC
Pharmacology; 2003 Apr; 67(4):182-94. PubMed ID: 12595749
[TBL] [Abstract][Full Text] [Related]
10. The novel analgesic and high-efficacy 5-HT1A receptor agonist, F 13640 induces c-Fos protein expression in spinal cord dorsal horn neurons.
Buritova J; Tarayre JP; Besson JM; Colpaert F
Brain Res; 2003 Jun; 974(1-2):212-21. PubMed ID: 12742639
[TBL] [Abstract][Full Text] [Related]
11. High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury.
Colpaert FC; Wu WP; Hao JX; Royer I; Sautel F; Wiesenfeld-Hallin Z; Xu XJ
Eur J Pharmacol; 2004 Aug; 497(1):29-33. PubMed ID: 15321732
[TBL] [Abstract][Full Text] [Related]
12. The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury.
Wu WP; Hao JX; Xu XJ; Wiesenfeld-Hallin Z; Koek W; Colpaert FC
Eur J Pharmacol; 2003 Oct; 478(2-3):131-7. PubMed ID: 14575797
[TBL] [Abstract][Full Text] [Related]
13. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief.
Colpaert FC
Curr Opin Investig Drugs; 2006 Jan; 7(1):40-7. PubMed ID: 16425670
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents.
Murai N; Hiyama H; Kiso T; Sekizawa T; Watabiki T; Oka H; Aoki T
Neuropharmacology; 2017 Nov; 126():97-107. PubMed ID: 28859883
[TBL] [Abstract][Full Text] [Related]
15. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
16. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses.
Paalzow GH
J Pharmacol Exp Ther; 1992 Nov; 263(2):470-9. PubMed ID: 1432683
[TBL] [Abstract][Full Text] [Related]
17. Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.
Bardin L; Colpaert FC
Eur J Pain; 2004 Jun; 8(3):253-61. PubMed ID: 15109976
[TBL] [Abstract][Full Text] [Related]
18. Nefopam and ketoprofen synergy in rodent models of antinociception.
Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM
Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069
[TBL] [Abstract][Full Text] [Related]
19. Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain.
Rezende RM; França DS; Menezes GB; dos Reis WG; Bakhle YS; Francischi JN
Br J Pharmacol; 2008 Feb; 153(4):760-8. PubMed ID: 18157167
[TBL] [Abstract][Full Text] [Related]
20. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
